The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
this that you know the semi blue type will be approved uh in the next year as a once a week drug the way we use it for diabetes and at a higher dose 2.4 milligrams rather than one milligram for the top dose and you know it's shown it's just best ever wage reduction and you know it's sort of an alternative to to bariatric surgery for these you know really overweight patients
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.